Literature DB >> 24124956

Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Jeffrey I Joseph1.   

Abstract

Patients managed in the intensive care units (ICUs) and general wards of the hospital experience a high incidence of hyperglycemia, hypoglycemia, and glycemic variability, despite significant hospital resources devoted to glucose control. Optimized glucose meters and monitoring systems are required to improve the safety and efficacy of insulin delivery and glucose control in the hospital. Safe insulin dosing requires timely and accurate glucose measurements, especially during dynamic changes in nutrition, insulin sensitivity, and physiological stress. In the current issue of Journal of Diabetes Science and Technology, Mitsios and coauthors describe the analytical accuracy of the new Accu-Check® Inform II blood glucose (BG) monitoring system commercialized by F. Hoffmann-La Roche Ltd. The point-of-care glucose meter achieved the desired degree of accuracy and precision, as defined by Clinical and Laboratory Standards Institute POCT12-A3 guidelines when evaluated using venous blood from 600 critically ill patients from multiple ICUs at two medical centers. Venous whole blood samples were used to obtain glucose meter results in duplicate. The remaining blood sample was centrifuged to obtain plasma for central hospital laboratory testing using the hexokinase method within 5 min of meter testing. A total of 98.8% of the 1200 Accu-Check Inform II meter's glucose values were within ± 12.5% (± 12 mg/dl) of the mean laboratory glucose value, and 99.8% were within ± 20% (± 20 mg/dl), thus meeting the Clinical and Laboratory Standards Institute criteria. Future studies are required to evaluate the clinical performance of the new BG monitoring system in the intended-use patient populations and critical care environments, using arterial, peripheral venous, central venous, and capillary blood samples.
© 2013 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24124956      PMCID: PMC3876373          DOI: 10.1177/193229681300700519

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  68 in total

Review 1.  Management of diabetes and hyperglycemia in hospitals.

Authors:  Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  What is accuracy and how close must the agreement be?

Authors:  James H Nichols
Journal:  Diabetes Technol Ther       Date:  2005-06       Impact factor: 6.118

Review 3.  Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects.

Authors:  Matthias Turina; Donald E Fry; Hiram C Polk
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

4.  Analytic evaluation of a new glucose meter system in 15 different critical care settings.

Authors:  John V Mitsios; Lori A Ashby; Doris M Haverstick; David E Bruns; Mitchell G Scott
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

5.  Accuracy of fingerstick glucose values in shock patients.

Authors:  H F Sylvain; M E Pokorny; S M English; N H Benson; T W Whitley; C J Ferenczy; J G Harrison
Journal:  Am J Crit Care       Date:  1995-01       Impact factor: 2.228

6.  Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.

Authors:  K Malmberg
Journal:  BMJ       Date:  1997-05-24

7.  Fingerstick glucose determination in shock.

Authors:  S H Atkin; A Dasmahapatra; M A Jaker; M I Chorost; S Reddy
Journal:  Ann Intern Med       Date:  1991-06-15       Impact factor: 25.391

Review 8.  Blood glucose measurement in the intensive care unit: what is the best method?

Authors:  Huong T Le; Neil S Harris; Abby J Estilong; Arvid Olson; Mark J Rice
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

9.  Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting.

Authors:  Katharina Maria Neubauer; Lukas Schaupp; Johannes Plank; Thomas Augustin; Selma Isabella Mautner; Bernd Tschapeller; Thomas Rudolf Pieber
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

10.  Impact of glucose measurement processing delays on clinical accuracy and relevance.

Authors:  Sujit R Jangam; Gary Hayter; Timothy C Dunn
Journal:  J Diabetes Sci Technol       Date:  2013-05-01
View more
  2 in total

Review 1.  Challenges of inpatient blood glucose monitoring: standards, methods, and devices to measure blood glucose.

Authors:  Kathie L Hermayer; Aundrea S Loftley; Sumana Reddy; Satya Nandana Narla; Nina A Epps; Yusheng Zhu
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

2.  The use of intramuscular glucagon to prevent IV glucose infusion in early neonatal hypoglycemia.

Authors:  Yair Kasirer; Ophir Dotan; Francis B Mimouni; Netanel Wasserteil; Cathy Hammerman; Alona Bin-Nun
Journal:  J Perinatol       Date:  2021-02-09       Impact factor: 2.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.